Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
12.30
-0.19 (-1.52%)
Jul 21, 2025, 4:00 PM - Market closed

Cogent Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
1,716862506808342350
Upgrade
Market Cap Growth
3.05%70.14%-37.32%136.30%-2.42%-
Upgrade
Enterprise Value
1,487644273605228365
Upgrade
Last Close Price
12.307.805.8811.568.5811.23
Upgrade
PS Ratio
-----44.52
Upgrade
PB Ratio
12.643.361.963.161.601.49
Upgrade
P/TBV Ratio
15.485.912.564.262.662.83
Upgrade
EV/Sales Ratio
-----46.36
Upgrade
Debt / Equity Ratio
0.080.070.070.080.020.02
Upgrade
Asset Turnover
-----0.05
Upgrade
Quick Ratio
4.985.156.969.6612.8618.50
Upgrade
Current Ratio
5.135.327.099.8713.0418.70
Upgrade
Return on Equity (ROE)
-84.04%-99.54%-74.94%-59.69%-32.20%-56.16%
Upgrade
Return on Assets (ROA)
-47.45%-53.78%-42.35%-34.68%-19.55%-14.69%
Upgrade
Return on Capital (ROIC)
-53.27%-62.67%-47.13%-37.51%-20.66%-15.89%
Upgrade
Earnings Yield
-15.71%-29.70%-38.00%-17.36%-21.14%-21.35%
Upgrade
FCF Yield
-12.99%-24.18%-30.89%-15.53%-17.69%-10.23%
Upgrade
Buyback Yield / Dilution
-113.08%-30.36%-35.54%-51.89%-249.52%-45.42%
Upgrade
Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q